Redwood City, CA, United States of America

Chunyan Song

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Genentech, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chunyan Song. Retrieved from https://idiyas.com/inventor/chunyan-song-42dn05lt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Chunyan Song

Introduction

Chunyan Song is a notable inventor based in Redwood City, CA (US). He has made significant strides in the field of cancer treatment through his innovative research and development. His work focuses on combination therapies that aim to enhance the effectiveness of cancer treatments.

Latest Patents

Chunyan Song holds a patent for the treatment of cancer using combination therapies comprising GDC-6036 and GDC-0077. This patent outlines methods that utilize GDC-6036 in conjunction with inavolisib to treat cancer effectively. His innovative approach has the potential to improve patient outcomes in cancer therapy.

Career Highlights

Chunyan Song is currently employed at Genentech, Inc., a leading biotechnology company known for its focus on developing medicines for serious medical conditions. His work at Genentech has allowed him to contribute to groundbreaking research in oncology.

Collaborations

Chunyan has collaborated with several talented individuals in his field, including Mark Merchant and Jennifer Lee Schutzman. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Chunyan Song's contributions to cancer treatment through his patented therapies exemplify the impact of innovative research in medicine. His work continues to inspire advancements in the fight against cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…